Rekombinanter VEGF (Bevacizumab Biosimilar) Antikörper

Produktnummer ABIN7487763

Produktdetails anti-VEGF (Bevacizumab Biosimilar) Antikörper

Target: VEGF (Bevacizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Maus

Klonalität: Chimeric

Konjugat: Dieser VEGF (Bevacizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), ELISA, Blocking Reagent (BR), Immunoprecipitation (IP), Western Blotting (WB)

Verwendungszweck: Anti-VEGF [Bevacizumab], Mouse IgG2a, kappa

Spezifität: This antibody binds native and reduced human VEGF (isoform 165).

Produktmerkmale:

Original Species of Ab: Human

Original Format of Ab: IgG1

Aufreinigung: Protein A affinity purified

Immunogen: Recombinant human VEGF.

Isotyp: IgG2a kappa

Anwendungsinformationen

Applikationshinweise: This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.

Kommentare:

This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Details zu VEGF (Bevacizumab Biosimilar)

Target: VEGF (Bevacizumab Biosimilar)

Abstract: VEGF (Bevacizumab Biosimilar) Produkte

Hintergrund: Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF

UniProt: P15692